Most Active Stories
- Bradley Completes 'Grid' Of 4,000-Footers, Every Mountain In Every Month
- Dartmouth Once Again Weighing Value Of Greek Life On Campus
- How Kickstarter Kept A North Country Cafe Open - And Kept It In The Family
- Freezing Rain Causes Treacherous Roadways, Multiple Accidents
- Bill Would Require N.H. Employers To Offer Five Sick Days Per Year
Mon April 23, 2012
Nestle To Buy Pfizer's Infant-Nutrition Line
RENEE MONTAGNE, HOST:
NPR's business news starts with an acquisition for Nestle.
(SOUNDBITE OF MUSIC)
MONTAGNE: Swiss food company Nestle announced today that it buy the infant nutrition business from the pharmaceutical company Pfizer. The move is likely aimed at boosting Nestle's presence in China. Nestle is paying just under $12 billion. It estimates 85 percent of this year's sales for that Pfizer unit will come from emerging markets. Before announcing this purchase, Nestle already had the largest share of the global baby-formula market at just under 20 percent. Transcript provided by NPR, Copyright NPR.